In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Merck sells out its stake in Du Pont Merck Pharmaceutical

Executive Summary

Merck will exercise its option to sell DuPont its half interest in DuPont Merck Pharmaceutical, the company they formed in 1990 as a joint venture. DuPont will pay $2.6bn (25 times earnings, agreed fair market value).
Deal Industry
  • Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Joint Venture

Related Companies